drugset / Trial / NCT03588026
Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576
RandomizedParallel-groupOpen-labelTreatment
Summary
rVA576 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).
Timeline
- Start
- 2018-06-07
- Primary completion
- 2020-09-03
- Completion
- 2020-09-03
Outcome
Met primary endpoint
release “The difference is statistically significant at the p=0.034 level.” akaritx.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rVA576 | Protein / enzyme biologic | — | Subcutaneous |